Cargando…

Lycorine: A prospective natural lead for anticancer drug discovery

Nature is the most abundant source for novel drug discovery. Lycorine is a natural alkaloid with immense therapeutic potential. Lycorine is active in a very low concentration and with high specificity against a number of cancers both in vivo and in vitro and against various drug-resistant cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Mridul, Liang, Long, Xiao, Xiaojuan, Feng, Peifu, Ye, Mao, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127747/
https://www.ncbi.nlm.nih.gov/pubmed/30114645
http://dx.doi.org/10.1016/j.biopha.2018.07.147
_version_ 1783516426816978944
author Roy, Mridul
Liang, Long
Xiao, Xiaojuan
Feng, Peifu
Ye, Mao
Liu, Jing
author_facet Roy, Mridul
Liang, Long
Xiao, Xiaojuan
Feng, Peifu
Ye, Mao
Liu, Jing
author_sort Roy, Mridul
collection PubMed
description Nature is the most abundant source for novel drug discovery. Lycorine is a natural alkaloid with immense therapeutic potential. Lycorine is active in a very low concentration and with high specificity against a number of cancers both in vivo and in vitro and against various drug-resistant cancer cells. This review summarized the therapeutic effect and the anticancer mechanisms of lycorine. At the same time, we have discussed the pharmacology and comparative structure-activity relationship for the anticancer activity of this compound. The researches outlined in this paper serve as a foundation to explain lycorine as an important lead compound for new generation anticancer drug design and provide the principle for the development of biological strategies to utilize lycorine in the treatment of cancers.
format Online
Article
Text
id pubmed-7127747
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71277472020-04-08 Lycorine: A prospective natural lead for anticancer drug discovery Roy, Mridul Liang, Long Xiao, Xiaojuan Feng, Peifu Ye, Mao Liu, Jing Biomed Pharmacother Article Nature is the most abundant source for novel drug discovery. Lycorine is a natural alkaloid with immense therapeutic potential. Lycorine is active in a very low concentration and with high specificity against a number of cancers both in vivo and in vitro and against various drug-resistant cancer cells. This review summarized the therapeutic effect and the anticancer mechanisms of lycorine. At the same time, we have discussed the pharmacology and comparative structure-activity relationship for the anticancer activity of this compound. The researches outlined in this paper serve as a foundation to explain lycorine as an important lead compound for new generation anticancer drug design and provide the principle for the development of biological strategies to utilize lycorine in the treatment of cancers. Elsevier Masson SAS. 2018-11 2018-08-14 /pmc/articles/PMC7127747/ /pubmed/30114645 http://dx.doi.org/10.1016/j.biopha.2018.07.147 Text en © 2018 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Roy, Mridul
Liang, Long
Xiao, Xiaojuan
Feng, Peifu
Ye, Mao
Liu, Jing
Lycorine: A prospective natural lead for anticancer drug discovery
title Lycorine: A prospective natural lead for anticancer drug discovery
title_full Lycorine: A prospective natural lead for anticancer drug discovery
title_fullStr Lycorine: A prospective natural lead for anticancer drug discovery
title_full_unstemmed Lycorine: A prospective natural lead for anticancer drug discovery
title_short Lycorine: A prospective natural lead for anticancer drug discovery
title_sort lycorine: a prospective natural lead for anticancer drug discovery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127747/
https://www.ncbi.nlm.nih.gov/pubmed/30114645
http://dx.doi.org/10.1016/j.biopha.2018.07.147
work_keys_str_mv AT roymridul lycorineaprospectivenaturalleadforanticancerdrugdiscovery
AT lianglong lycorineaprospectivenaturalleadforanticancerdrugdiscovery
AT xiaoxiaojuan lycorineaprospectivenaturalleadforanticancerdrugdiscovery
AT fengpeifu lycorineaprospectivenaturalleadforanticancerdrugdiscovery
AT yemao lycorineaprospectivenaturalleadforanticancerdrugdiscovery
AT liujing lycorineaprospectivenaturalleadforanticancerdrugdiscovery